Home > Insider Trading > Filing (0001209191-20-019349)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460702	Ritter Pharmaceuticals Inc	RTTR	Pharmaceutical Preparations (2834)	263474527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631673	Noah Doyle	Ritter Pharmaceuticals, Inc. 1880 Century Park East, Suite 1000 Los Angeles CA 90067		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-03-12	500,000	$0.22	704,780	No	4	S	Indirect	By Javelin Partners, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Javelin Partners, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	32,275	Indirect	By Javelin Venture Partners I SPV I, LLC
Common Stock	2,272	Direct

Footnotes

The Reporting Person sold the securities in open market transactions at prices ranging from $0.22 to $0.23 per share, with a weighted average sale price of $0.22 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares sold at each separate price.
As the managing director of Javelin Partners, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.
As the managing director of Javelin Venture Partners I SPV I, LLC, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.